Helle Fisker

Helle Fisker holds an MSc in Biotech Engineering with a specialty in Immunology from the Technical University of Denmark and an Executive MBA from Copenhagen Business School. For the past 20 years, she has worked in sales and marketing roles for oncology and cancer diagnostic companies and executed multiple global product launches and Go to Market commercial strategies for companies GSK, Dako (now Agilent), Leica Biosystems, and taken new products to the European markets for SME ViroGates and Visiopharm. Before joining Biovica, Helle Fisker worked as a strategy and market consultant for companies, i.e., Sysmex, Diaceutics, Tieto, and Pathcore, working with advanced, core, genetic, and digital cancer diagnostics and oncology.

Ongoing assignments: Board member at Qlucore AB and FlowRobotics A/S.

Holdings: 58 750 Class B shares.
Stock options: 12 600 SSP 24/27: 1 RSU and 37 800 SSP 24/27:1 PRSU.